Published in Cell Stem Cell on August 06, 2010
Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell (2011) 8.21
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell (2010) 5.13
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol (2011) 4.77
CellNet: network biology applied to stem cell engineering. Cell (2014) 4.10
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Next-generation proteomics: towards an integrative view of proteome dynamics. Nat Rev Genet (2012) 2.39
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med (2013) 2.10
Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci (2011) 2.09
Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09
Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol (2013) 1.91
Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell (2010) 1.81
Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.69
Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol (2011) 1.69
Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell (2013) 1.63
Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet (2014) 1.53
The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol Syst Biol (2011) 1.44
Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.32
Molecular control of induced pluripotency. Cell Stem Cell (2014) 1.22
Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep (2014) 1.16
Functional modules distinguish human induced pluripotent stem cells from embryonic stem cells. Stem Cells Dev (2011) 1.15
Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res (2012) 1.12
A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Nat Biotechnol (2015) 1.09
A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells. Stem Cell Reports (2013) 1.08
Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol Ther (2011) 1.05
Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate? PLoS One (2010) 1.02
Recreating pluripotency? Cell Stem Cell (2010) 1.02
Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells. PLoS One (2012) 0.98
Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol (2013) 0.98
Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells. BMC Syst Biol (2011) 0.96
Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res (2013) 0.92
A quantitative system for discriminating induced pluripotent stem cells, embryonic stem cells and somatic cells. PLoS One (2013) 0.91
Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells. BMC Neurosci (2011) 0.90
New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells. Hum Gene Ther (2013) 0.89
Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro. Alcohol Clin Exp Res (2012) 0.89
Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks. Stem Cells Int (2011) 0.89
Pluripotent stem cells and gene therapy. Transl Res (2013) 0.88
Stem cell therapy: an exercise in patience and prudence. Philos Trans R Soc Lond B Biol Sci (2013) 0.86
Myogenic Differentiation of Mouse Embryonic Stem Cells That Lack a Functional Pax7 Gene. Stem Cells Dev (2016) 0.86
How microRNAs facilitate reprogramming to pluripotency. J Cell Sci (2012) 0.85
Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. J Am Coll Cardiol (2016) 0.85
Methods of induced pluripotent stem cells for clinical application. World J Stem Cells (2015) 0.85
Emerging stem cell therapies: treatment, safety, and biology. Stem Cells Int (2012) 0.83
A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells. PLoS One (2015) 0.83
Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Sci Rep (2013) 0.82
Pluripotency of induced pluripotent stem cells. J Anim Sci Biotechnol (2012) 0.82
Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells. PLoS One (2015) 0.81
The evolving biology of cell reprogramming. Philos Trans R Soc Lond B Biol Sci (2011) 0.81
Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives. Stem Cell Rev (2012) 0.81
Assumption weighting for incorporating heterogeneity into meta-analysis of genomic data. Bioinformatics (2012) 0.81
A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells. PLoS One (2011) 0.80
Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening. Biotechnol Adv (2016) 0.79
Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives. Methods Mol Biol (2013) 0.79
Biology of the Mi-2/NuRD Complex in SLAC (Stemness, Longevity/Ageing, and Cancer). Gene Regul Syst Bio (2011) 0.79
The State of Play with iPSCs and Spinal Cord Injury Models. J Clin Med (2015) 0.79
Transcriptomic analysis of pluripotent stem cells: insights into health and disease. Genome Med (2011) 0.78
Epigenetics of pluripotent cells. Acta Naturae (2012) 0.78
Standardization of human stem cell pluripotency using bioinformatics. Stem Cell Res Ther (2013) 0.78
Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray. PLoS One (2014) 0.78
The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture. PLoS One (2016) 0.78
Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells. J Allergy Clin Immunol (2014) 0.77
Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair. Curr Opin Genet Dev (2014) 0.77
Reprogramming resistant genes: in-depth comparison of gene expressions among iPS, ES, and somatic cells. Front Physiol (2013) 0.77
Tinkering with transcription factors uncovers plasticity of somatic cells. Genes Cancer (2010) 0.77
Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming. Cell Cycle (2015) 0.77
Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering. Stem Cells Int (2012) 0.77
Epigenetic Modulations of Induced Pluripotent Stem Cells: Novel Therapies and Disease Models. Drug Discov Today Dis Models (2012) 0.76
Differentiation of stem cells upon deprivation of exogenous FGF2: a general approach to study spontaneous differentiation of hESCs in vitro. Syst Biol Reprod Med (2012) 0.76
A web-server of cell type discrimination system. ScientificWorldJournal (2014) 0.76
Meta-analysis based on weighted ordered P-values for genomic data with heterogeneity. BMC Bioinformatics (2014) 0.75
Describing the Stem Cell Potency: The Various Methods of Functional Assessment and In silico Diagnostics. Front Cell Dev Biol (2016) 0.75
Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells. Int J Mol Sci (2017) 0.75
Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts. PLoS One (2017) 0.75
Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation. Arch Immunol Ther Exp (Warsz) (2016) 0.75
KATapulting toward Pluripotency and Cancer. J Mol Biol (2016) 0.75
Present and future challenges of induced pluripotent stem cells. Philos Trans R Soc Lond B Biol Sci (2015) 0.75
MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platforms. BMC Bioinformatics (2017) 0.75
The silver lining of induced pluripotent stem cell variation. Stem Cell Investig (2016) 0.75
Pluripotent Stem Cells and Skeletal Regeneration--Promise and Potential. Curr Osteoporos Rep (2015) 0.75
A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells. PLoS One (2016) 0.75
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med (2012) 1.46
AutoSOME: a clustering method for identifying gene expression modules without prior knowledge of cluster number. BMC Bioinformatics (2010) 1.37
XSTREAM: a practical algorithm for identification and architecture modeling of tandem repeats in protein sequences. BMC Bioinformatics (2007) 1.28
Global analysis of proline-rich tandem repeat proteins reveals broad phylogenetic diversity in plant secretomes. PLoS One (2011) 0.78
Efficient selection of biomineralizing DNA aptamers using deep sequencing and population clustering. ACS Nano (2013) 0.75
Identifying stem cell gene expression patterns and phenotypic networks with AutoSOME. Methods Mol Biol (2014) 0.75